Concord Drugs Ltd — Board Meeting, 16-05-2025: Board Meeting

Concord Drugs Limited has announced a board meeting to consider and approve the financial results for the quarter and year ended March 31, 2025. The company has initiated a trading window closure for designated persons starting April 1, 2025, until 48 hours after the financial results are made public. This step ensures compliance with insider trading policies and signals upcoming financial disclosures that will impact investor decisions.